These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19345895)

  • 21. Predicting impacts of mass-screening policy changes on breast cancer mortality.
    Seppänen J; Heinävaara S; Hakulinen T
    Stat Med; 2008 Nov; 27(25):5235-51. PubMed ID: 18613224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organizational aspects of breast cancer screening in Sarajevo region.
    Obralic N; Cuplov M; Softic Dz; Musanovic M; Softic A; Dizdarevic Z; Kurtovic M; Dalagija F; Dzapo M; Basic H; Urlic J; Kadic A
    J BUON; 2008; 13(4):553-7. PubMed ID: 19145679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Informed choice requires information about both benefits and harms.
    Jørgensen KJ; Brodersen J; Hartling OJ; Nielsen M; Gøtzsche PC
    J Med Ethics; 2009 Apr; 35(4):268-9. PubMed ID: 19332586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Information about tests for breast cancer: what are we telling people?
    Croft E; Barratt A; Butow P
    J Fam Pract; 2002 Oct; 51(10):858-60. PubMed ID: 12401156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underestimation of breast cancer risk: influence on screening behavior.
    Katapodi MC; Dodd MJ; Lee KA; Facione NC
    Oncol Nurs Forum; 2009 May; 36(3):306-14. PubMed ID: 19403452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overuse of mammography during the first round of an organized breast cancer screening programme.
    Chamot E; Charvet A; Perneger TV
    J Eval Clin Pract; 2009 Aug; 15(4):620-5. PubMed ID: 19522725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the impact of breast cancer screening in South Australia.
    Tallis GM; O'Neill TJ
    Intern Med J; 2009 Mar; 39(3):174-8. PubMed ID: 19383066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Information provided by Italian breast cancer screening programmes: a comparison between 2001 and 2014.
    Castagno R; Canuti D; Petrella M; Bucchi L; Fedato C; Garena F; Giordano L
    Epidemiol Prev; 2015; 39(3 Suppl 1):48-51. PubMed ID: 26405776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. State-level differences in breast and cervical cancer screening by disability status: United States, 2008.
    Armour BS; Thierry JM; Wolf LA
    Womens Health Issues; 2009; 19(6):406-14. PubMed ID: 19879454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast cancer screening in France].
    Philip T; Kasparian C; Fagnani F; Moatti JP; Meunier A
    Bull Acad Natl Med; 2005 Feb; 189(2):321-36; discussion 336-9. PubMed ID: 16114862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. League tables of breast cancer screening units: worst-case and best-case scenario ratings helped in exposing real differences between performance ratings.
    Lemmers O; Broeders M; Verbeek A; Heeten Gd; Holland R; Borm GF
    J Med Screen; 2009; 16(2):67-72. PubMed ID: 19564518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
    Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
    Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking bad news in the breast imaging setting.
    Adler DD; Riba MB; Eggly S
    Acad Radiol; 2009 Feb; 16(2):130-5. PubMed ID: 19124097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Screening of breast cancer].
    Pamilo M
    Duodecim; 2001; 117(19):1885-6. PubMed ID: 12181918
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Information preferences of high literacy pregnant women regarding informed consent models for genetic carrier screening.
    Ormond KE; Banuvar S; Daly A; Iris M; Minogue J; Elias S
    Patient Educ Couns; 2009 May; 75(2):244-50. PubMed ID: 19013744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.
    Casamitjana M; Sala M; Ochoa D; Fusté P; Castells X; Alameda F;
    Eur J Public Health; 2009 Oct; 19(5):499-503. PubMed ID: 19435798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.